NCT07932626 Virtual Reality Education Before CyberKnife Treatment for Prostate Cancer
| NCT ID | NCT07932626 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Ostrava |
| Condition | Prostate Cancer Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-08-01 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study evaluates virtual reality education for men aged 40 to 80 years with prostate cancer who are scheduled for CyberKnife radiotherapy at the University Hospital Ostrava. Participants are assigned in a 1:1 ratio to standard patient education alone or standard education supplemented by the Virtual Doctor's Assistant. The virtual environment reproduces the CyberKnife treatment room and explains the equipment, the treatment process, and the importance of consistent bladder and rectal preparation. The study aims to reduce stress before treatment and improve patients' understanding of the procedure and preparation requirements. Cancer treatment itself is unchanged. Outcomes will be assessed using patient questionnaires.
Eligibility Criteria
Inclusion Criteria: * Male patients aged 40 to 80 years * Diagnosis of prostate cancer * Indication for CyberKnife SBRT at the Oncology Department of University Hospital Ostrava * Written informed consent to participate in the study Exclusion Criteria: * Not signing the informed consent
Contact & Investigator
Lukáš Knybel, Assoc.Prof., Ing., Ph.D.
PRINCIPAL INVESTIGATOR
University Hospital Ostrava
Frequently Asked Questions
Who can join the NCT07932626 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 80 Years, studying Prostate Cancer Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07932626 currently recruiting?
Yes, NCT07932626 is actively recruiting participants. Contact the research team at lukas.knybel@fno.cz for enrollment information.
Where is the NCT07932626 trial being conducted?
This trial is being conducted at Ostrava, Czechia.
Who is sponsoring the NCT07932626 clinical trial?
NCT07932626 is sponsored by University Hospital Ostrava. The principal investigator is Lukáš Knybel, Assoc.Prof., Ing., Ph.D. at University Hospital Ostrava. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.